Sn. Pimstone et al., MUTATIONS IN THE GENE FOR LIPOPROTEIN-LIPASE - A CAUSE FOR LOW HDL CHOLESTEROL LEVELS IN INDIVIDUALS HETEROZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA, Arteriosclerosis, thrombosis, and vascular biology, 15(10), 1995, pp. 1704-1712
Familial hypercholesterolemia (FH) is characterized by elevated plasma
concentrations of LDL cholesterol resulting from mutations in the gen
e for the LDL receptor. Low HDL cholesterol levels are seen frequently
in patients bath heterozygous and homozygous for mutations in this ge
ne. Suggested mechanisms for reduced HDL levels in FH patients have be
en altered apolipoprotein A-1 metabolism and elevated cholesteryl este
r transfer protein activity, but the molecular basis for hypoalphalipo
proteinemia in any of these patients has not yet been identified. We i
nvestigated four large families in which individuals were found to be
double heterozygotes for both FH and lipoprotein lipase (LPL) deficien
cy. These double heterozygotes have significantly less HDL cholesterol
than persons with FH or LPL heterozygosity alone. In the double heter
ozygotes, HDL particle composition is not significantly different from
FH heterozygotes, suggesting a quantitative rather than qualitative d
efect in HDL metabolism in these persons. We propose that mutations in
the LPL gene may be a cause of low HDL cholesterol levels in some ind
ividuals heterozygous for FH.